If you want to know Bionaturis Group latest news, here you are our June Newsletter

Imagen Bionaturis Newsletter

IN THIS ISSUE

    • Zera®-2 patent of ZIP Solutions also granted in USA

 

    • Bionaturis Group in the MedCap Forum

 

  • Bionaturis Group takes part in two events in USA in June

Let’s get to know…

Sara Eslava Alcon, 23 years old, born in Jerez (Cadiz). Degree in Biotechnology by Cadiz University.

 

 

Sara Eslava

  • -When you were a child, what did you want to be as an adult?
  • I dreamt of becoming a gymnast because I loved practising and it made me feel good when I was a child.
  • -What do you like the most about your job?
  • Being able of discovering new things every day.
  • -What are your future challenges?
  • To continue training and learning from people and academically both.
  • -Your favourite dish
  • Meatballs with tomato and fries.
  • -A place
  • Anyone near of nature, such as beaches, paths…
  • -A film
  • ‘Inception’, by Christopher Nolan.
  • -A historical figure
  • Rosalind Franklin.
  • -A book
  • ‘The Name of the Wind’, by Patrick Rothfuss.
  • -A song
  • “This I love”, de Guns N’ Roses.
  • -What do you usually do in your free time?
  • I like going to the cinema, training and dancing.
  • -You can’t live without…
  • Dancing, because when I am dancing I can totally get away and simply enjoy the moment.
  • -How do you imagine the world in 20 years?
  • I think our current economic situation will improve and, therefore, the general well-being.
  Sara has been doing a trainee as a Lab Technician in Bionaturis since November, 2016.

Zera®-2 patent of ZIP Solutions also granted
in USA

ZIP Solutions –Bionaturis Group- has just been granted with a new patent titled “Protein Body-inducing Polypeptide Sequences” for EEUU, becoming the third patent of the same family, already obtained for Japan and Europe. This patent contributes to a better protection of the Zera Subunit Vaccines 2.0 and Zera DNA Vaccines outstanding applications […] Read more

Bionaturis Group
in the MedCap Forum

Once again Bionaturis Group takes part in the Small and Medium-Sized Companies Forum (MedCap), organized by BME. The biotechnological group showcased the milestones achieved lately such as the YoY growth on net sales and revenues and Evaluation and Option agreement to register and commercialize worldwide the Bionaturis´ visceral canine leishmaniasis vaccine –BNT005- or the recent license contract with Biotandil to register, manufacture and market the same vaccine, in this case limited to Argentina and Paraguay. The full corporate presentation is available here […] Read more

Bionaturis Group takes part in two events in USA in June

Bionaturis Group representatives will showcase the biotechnological group offer in two relevant events in USA in June: the World Preclinical Congress (Boston) and the Bio International Convention (San Diego) […] Read more

INVESTOR INFO

Relevant info. Presentation of stategic plans, projects and forecasts. MedCap Forum Corporate Presentation (30/5/2017 17.44h) Relevant info. R&D, results, licenses, patents and products. New patent in USA for ZIP Solutions (29/5/2017 17.47h) (Only in Spanish)
Related to Relevant Information 09/03/2017 08.32h)

Relevant info: Notice and Agreements of Shareholders meetings. Notice of the Ordinary General Shareholders Meeting (19/05/2017 18.11h)

Notice of the Ordinary General Shareholders Meeting (19/5/2017 18.28h)

Proposals for the Ordinary General Shareholders Meeting (19/5/2017 18.19h) (Only in Spanish)

Board of Directors Report (19/5/2017 18.22h)(Only in Spanish)

 

Hi, this newsletter contains information about my website. For any question, please contact to info@bionaturis.com
Imagen Boletín Bionaturis Imagen Twitter Bionaturis Imagen Linked In Bionaturis Imagen Flickr Bionaturis Imagen Youtube Bionaturis Imagen Blog Bionaturis

 

Este e-mail ha sido enviado por *|EMAIL|*¿Por qué me sale esto?    No quiero seguir recibiendo este newsletter    Actualizar las preferencias de suscripción*|LIST:ADDRESSLINE|*

*|REWARDS|*